Sofosbuvir Recruiting Phase 4 Trials for Hepatitis C Viral Infection / Respiratory Failure Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03625687Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant